TIMONY, Gregg,GUJRATHI, Sheila,PEACH, Robert,OLSON, Allan
申请号：
EP17790401
公开号：
EP3448391A4
申请日:
2017.04.27
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention is directed to methods for treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment, a composition containing an inter leukin- 13 (IL-13) antibody, or an antigen binding fragment, thereof.
